Delivery Order SPE2DB25D3005-SPE2DB25FQBGL

Award Date 12/26/24
Potential Completion Date 12/27/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB25D3005
    Indefinite Delivery Contract
  • SPE2DB25D3005-SPE2DB25FQBGL
    Delivery Order

This federal contract award, with an ID of SPE2DB25D3005|SPE2DB25FQBGL, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $2,293.50, is a delivery order for the supply of 4566798875 VYVANSE 40 MG CAPSULE 100S. The award has an ultimate completion date of December 27, 2024 and is a Firm Fixed Price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 3/27/25, 9:48 AM